AmberGen’s state-of-the-art MALDI Imaging facility provides label-free drug screening services based on its patented revolutionary Bead-AMS™ proteomic technology. This approach is especially useful to identify on and off-target hits against a library of proteins such as the kinome and can provide information about potential adverse drug side-effects and drug repurposing. Contact us to learn more.
Development of High-throughput, Accurate, Multiplex Immuno-Diagnostic Assays
AmberGen provides services to develop custom immunodiagnostics which incorporate our proprietary PC-PURE™ technology and bead-based automation methodology for gold-standard diagnostic performance and industry-leading throughput. Contact us to learn more.
Mass Spectrometric Imaging
AmberGen offers in-house mass spectrometric imaging services for advanced tissue and array scanning using state-of-the-art instruments and methodology to suit your research needs. Our experts will work with you to provide optimal research solutions. Contact us to learn more.
Get in Touch
313 Pleasant St.
Watertown, MA 02472
- Dr. Gargey Yagnik joins AmberGen as Program Coordinator for Mass Spectrometry. In his previous position as a postdoctoral researcher at Sanofi Genzyme he developed new methods for MALDI-MSI tissue imaging. He received his Ph.D. from Iowa State University in analytical chemistry. January 2017
- AmberGen awarded two US Patents (9,334,530 and 9,523,680) providing broad coverage for its Bead-AMS™ technology December 2016